Clinical Trial Update: Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Disorder [NA]

View source ↗

Summary

A pivotal randomized trial evaluating the safety and efficacy of the digital therapeutic ANZEILAX for Generalized Anxiety Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• ANZEILAX

Snippet

Sponsor: HAII corp.ltd | Conditions: Generalized Anxiety Disorder | NA | Status: COMPLETED